| 000 | 01729 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517014138.0 | ||
| 264 | 0 | _c20160315 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1365-2265 | ||
| 024 | 7 |
_a10.1111/cen.12731 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPuig Domingo, Manuel | |
| 245 | 0 | 0 |
_aTreatment of acromegaly in the era of personalized and predictive medicine. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cJul 2015 |
||
| 300 |
_a3-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdenoma _xgenetics |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aArrestins _xmetabolism |
| 650 | 0 | 4 |
_aCadherins _xmetabolism |
| 650 | 0 | 4 |
_aGrowth Hormone-Secreting Pituitary Adenoma _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aKi-67 Antigen _xmetabolism |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeurosurgical Procedures |
| 650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
| 650 | 0 | 4 |
_aPeptides, Cyclic _xtherapeutic use |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Somatostatin _xmetabolism |
| 650 | 0 | 4 |
_aSomatostatin _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 | _abeta-Arrestin 1 |
| 650 | 0 | 4 | _abeta-Arrestins |
| 650 | 0 | 4 |
_araf Kinases _xmetabolism |
| 773 | 0 |
_tClinical endocrinology _gvol. 83 _gno. 1 _gp. 3-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cen.12731 _zAvailable from publisher's website |
| 999 |
_c24584212 _d24584212 |
||